Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 412

1.

Screening for aspirin resistance in stable coronary artery patients by three different tests.

Chakroun T, Addad F, Abderazek F, Ben-Farhat M, Hamdi S, Gamra H, Hassine M, Ben-Hamda K, Samama MM, Elalamy I.

Thromb Res. 2007;121(3):413-8. Epub 2007 Jun 5.

PMID:
17553552
2.

A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.

Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG.

Eur Heart J. 2007 Jul;28(14):1702-8. Epub 2007 Jun 14.

PMID:
17569678
3.

The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.

Can MM, Tanboğa IH, Türkyilmaz E, Karabay CY, Akgun T, Koca F, Tokgoz HC, Keles N, Ozkan A, Bezgin T, Ozveren O, Sonmez K, Sağlam M, Ozdemir N, Kaymaz C.

Thromb Res. 2010 Apr;125(4):e132-7. doi: 10.1016/j.thromres.2009.11.005. Epub 2009 Dec 1.

PMID:
19954823
4.

Factors responsible for "aspirin resistance" - can we identify them?

Postuła M, Tarchalska-Kryńska B, Filipiak KJ, Kosior D, Serafin A, Huczek Z, Opolski G.

Kardiol Pol. 2010 Apr;68(4):403-11; discussion 412-3.

5.

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.

Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.

Circulation. 2007 Jun 26;115(25):3156-64. Epub 2007 Jun 11.

6.

Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease.

Christiaens L, Macchi L, Herpin D, Coisne D, Duplantier C, Allal J, Mauco G, Brizard A.

Thromb Res. 2002 Nov 1;108(2-3):115-9.

PMID:
12590946
7.

Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease.

Addad F, Chakroun T, Abderazek F, Ben-Farhat M, Hamdi S, Dridi Z, Gamra H, Hassine M, Samama MM, Elalamy I.

J Thromb Thrombolysis. 2010 Jan;29(1):108-13. doi: 10.1007/s11239-009-0335-1.

PMID:
19381450
8.

Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.

Frelinger AL 3rd, Li Y, Linden MD, Barnard MR, Fox ML, Christie DJ, Furman MI, Michelson AD.

Circulation. 2009 Dec 22;120(25):2586-96. doi: 10.1161/CIRCULATIONAHA.109.900589. Epub 2009 Dec 7.

9.

Aspirin non-responsiveness in Korean subjects on dual anti-platelet treatment determined by two different platelet function assays.

Lee YW, Cho YH, Kim YH, Na JS, Shin HB, Ki CS, Choi TY, Lee YK.

Ann Clin Lab Sci. 2008 Spring;38(2):126-31.

PMID:
18469357
10.
11.

[Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].

Malý J, Pecka M, Gregor J, Dulícek P, Blazek M, Malý R, Pudil R, Bláha M.

Cas Lek Cesk. 2005;144 Suppl 3:23-9. Czech.

PMID:
16335259
13.

Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease.

Andersen K, Hurlen M, Arnesen H, Seljeflot I.

Thromb Res. 2002 Oct 1;108(1):37-42.

PMID:
12586130
14.

Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.

McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Lawrie AS, Purdy G, Machin SJ, Brown MM.

Platelets. 2005 Aug;16(5):269-80.

PMID:
16011977
15.

Relationship between the serum sCD40L level and aspirin-resistant platelet aggregation in patients with stable coronary artery disease.

Pamukcu B, Oflaz H, Onur I, Midilli K, Yilmaz G, Yilmaz E, Nisanci Y.

Circ J. 2008 Jan;72(1):61-6.

16.

The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.

Bach J, Kammerer I, Isgro F, Haubelt H, Vogt A, Saggau W, Hellstern P.

Platelets. 2009 May;20(3):150-7. doi: 10.1080/09537100902780650.

PMID:
19437331
17.

Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry.

Nielsen HL, Kristensen SD, Thygesen SS, Mortensen J, Pedersen SB, Grove EL, Hvas AM.

Thromb Res. 2008;123(2):267-73. doi: 10.1016/j.thromres.2008.03.023. Epub 2008 May 21.

PMID:
18499236
18.

Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.

Faraday N, Becker DM, Yanek LR, Herrera-Galeano JE, Segal JB, Moy TF, Bray PF, Becker LC.

Am J Cardiol. 2006 Sep 15;98(6):774-9. Epub 2006 Jul 28.

PMID:
16950183
19.

Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.

Li J, Jian Z, Huang L, Guo H, Huang J, Qian D, Fu W, Li A, Song Y.

Biomed Pharmacother. 2009 Sep;63(8):608-12. doi: 10.1016/j.biopha.2008.10.004. Epub 2008 Oct 31.

PMID:
19019624
20.

Antiplatelet effect of aspirin in patients with coronary artery disease.

Grove EL.

Dan Med J. 2012 Sep;59(9):B4506. Review.

PMID:
22951204

Supplemental Content

Support Center